PSI Advisors, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
PSI Advisors, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,659
-66.3%
1,2750.0%0.01%
-64.3%
Q2 2023$31,671
+65.2%
1,2750.0%0.01%
+55.6%
Q1 2023$19,176
+27.1%
1,2750.0%0.01%
+12.5%
Q4 2022$15,083
+88.5%
1,2750.0%0.01%
+100.0%
Q3 2022$8,000
+60.0%
1,2750.0%0.00%
+100.0%
Q2 2022$5,000
+66.7%
1,275
+363.6%
0.00%
+100.0%
Q1 2022$3,000
-87.5%
275
-78.4%
0.00%
-90.0%
Q4 2021$24,000
-65.7%
1,275
-39.3%
0.01%
-68.8%
Q3 2021$70,0002,1000.03%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders